Showing 101 - 120 results of 166 for search '"leishmaniasis"', query time: 0.07s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104

    The leishmaniases in Kenya: A scoping review. by Grace Grifferty, Hugh Shirley, Katherine O'Brien, Jason L Hirsch, Adrienne M Orriols, Kiira Lani Amechi, Joshua Lo, Neeharika Chanda, Sarra El Hamzaoui, Jorja Kahn, Samantha V Yap, Kyleigh E Watson, Christina Curran, Amina Atef AbdelAlim, Neeloy Bose, Alissa Link Cilfone, Richard Wamai

    Published 2023-06-01
    “…Endemic in over 100 countries, the four types of leishmaniasis-visceral leishmaniasis (VL) (known as kala-azar), cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and post-kala-azar dermal leishmaniasis (PKDL)-put 1.6 billion people at risk. …”
    Get full text
    Article
  5. 105

    Sex-Related Differences in Immune Response and Symptomatic Manifestations to Infection with Leishmania Species by Ryan D. Lockard, Mary E. Wilson, Nilda E. Rodríguez

    Published 2019-01-01
    “…Herein, we review the distribution, morbidity, and mortality among male and female leishmaniasis patients. Additionally, we discuss experimental findings and new avenues of research concerning sex-specific responses in cutaneous and visceral leishmaniasis. …”
    Get full text
    Article
  6. 106
  7. 107

    Inflammatory Nasal Swelling due to Leishmania tropica by Hajiba Fellah, Maryam Hakkour, Bouchra Delouane, Asmae Hmamouch, Abdelhakim Bouyahya, Faiza Sebti, Abderrahim Sadak

    Published 2021-01-01
    “…Since its discovery in the 19th century, cutaneous leishmaniasis has been a major public health problem, especially with the appearance of more and more unusual cases of cutaneous lesions due to this parasite. …”
    Get full text
    Article
  8. 108

    Developments in Diagnosis and Antileishmanial Drugs by Prachi Bhargava, Rajni Singh

    Published 2012-01-01
    “…Leishmaniasis is a diverse group of clinical syndromes caused by protozoan parasites of the genus Leishmania. …”
    Get full text
    Article
  9. 109

    Strategies to Overcome Antileishmanial Drugs Unresponsiveness by Shyam Sundar, Anup Singh, Om Prakash Singh

    Published 2014-01-01
    “…In the absence of effective vector control measures and vaccines against leishmaniasis, effective chemotherapy remains the mainstay of treatment. …”
    Get full text
    Article
  10. 110

    Synthesis and evaluation of nitrochromene derivatives as potential antileishmanial therapeutics through biological and computational studies by Niloofar Javid, Ali Asadipour, Ehsan Salarkia, Mohammad Amin Langarizadeh, Fatemeh Sharifi, Mohammad Mahdavi, Bagher Amirheidari, Aida Iraji, Hojjat Rezaiezadeh, Gholamreza Hassanpour, Yaghoub Pourshojaei

    Published 2025-01-01
    “…Abstract Leishmaniasis is a parasitic disease caused by protozoan organisms belonging to the Leishmania genus, affecting many individuals worldwide, with the burden surpassing one million cases. …”
    Get full text
    Article
  11. 111
  12. 112

    Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection by Marion M. Chan, Nagasuresh Adapala, Cui Chen

    Published 2012-01-01
    “…Infection is the outcome of a contest between a pathogen and its host. In the disease leishmaniasis, the causative protozoan parasites are harbored inside the macrophages. …”
    Get full text
    Article
  13. 113

    YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates by Inés Bouzón-Arnáiz, Mukul Rawat, Rachael Coyle, Lionel Brice Feufack-Donfack, Malen Ea, Agnes Orban, Jean Popovici, Lucía Román-Álamo, Antonino Nicolò Fallica, Bárbara Domínguez-Asenjo, Javier Moreno, Elsa M. Arce, Ana Mallo-Abreu, Diego Muñoz-Torrero, Marcus C. S. Lee, Xavier Fernàndez-Busquets

    Published 2025-01-01
    “…Tests performed in clinical isolates indicated that YAT2150 had also strong activity against Plasmodium vivax (IC50 between 4 and 36 nM) and Leishmania infantum (1.27 and 1.11 µM), placing it as a unique compound with perspectives of becoming the first drug to be used against both malaria and leishmaniasis.…”
    Get full text
    Article
  14. 114

    Dyarrheal Syndrome in a Patient Co-Infected with Leishmania infantum and Schistosoma mansoni by Gláucia Fernandes Cota, Luciana Inácia Gomes, Bruna Fernandes Pinto, Joanna R. Santos-Oliveira, Alda Maria Da-Cruz, Moisés Salgado Pedrosa, Wagner Luiz Tafuri, Ana Rabello

    Published 2012-01-01
    “…This case report describes an atypical clinical presentation of visceral leishmaniasis affecting the digestive tract and causing malabsorption syndrome in a patient without recognized immunosuppressive condition. …”
    Get full text
    Article
  15. 115
  16. 116

    Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease by Daniel Feijó, Rafael Tibúrcio, Mariana Ampuero, Cláudia Brodskyn, Natalia Tavares

    Published 2016-01-01
    “…Leishmaniasis is a group of neglected diseases whose clinical manifestations depend on factors from the host and the pathogen. …”
    Get full text
    Article
  17. 117
  18. 118

    Novel Arsenic Nanoparticles Are More Effective and Less Toxic than As (III) to Inhibit Extracellular and Intracellular Proliferation of Leishmania donovani by Sudipta Chakraborty, Kaushik Bhar, Sandip Saha, Rajarshi Chakrabarti, Anjali Pal, Anirban Siddhanta

    Published 2014-01-01
    “…Visceral leishmaniasis, a vector-borne tropical disease that is threatening about 350 million people worldwide, is caused by the protozoan parasite Leishmania donovani. …”
    Get full text
    Article
  19. 119

    Comparing the Trends of Vector-Borne Diseases (VBDs) before and after the COVID-19 Pandemic and Their Spatial Distribution in Southern Iran by Zahra Gheibi, Mitra Boroomand, Aboozar Soltani

    Published 2023-01-01
    “…However, the difference between observed and expected values revealed that the consequences of the COVID-19 pandemic had increased the number of leishmaniasis cases. Conclusion. Tropical regions of Iran, including Fars province, are the favorite destinations for travelers. …”
    Get full text
    Article
  20. 120

    La Leishmaniosis by Jorge R. Rey

    Published 2007-08-01
    “…Rey, is the Spanish language version of ENY-738: Leishmaniasis. It describes this disease caused by parasitic protozoans transmitted to humans by sandflies. …”
    Get full text
    Article